Suchergebnisse - "Welters, Marij J P"

PubPharm (183)

1

CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors

enthalten in: Cellular & molecular immunology | 2024

von Lei, X. | de Groot, D. | Welters, M. | +13

2

Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies

enthalten in: Cancer immunology research | 2024

von Groeneveldt, C. | Kinderman, P. | Griffioen, L. | +11

3

The combined HPV16-E2/E6/E7 T cell response in oropharyngeal cancer predicts superior survival

enthalten in: Cell reports. Medicine | 2023

von Santegoets, S. | Stolk, A. | Welters, M. | +1

4

Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer

enthalten in: Journal for immunotherapy of cancer | 2023

von Verdegaal, E. | Santegoets, S. | Welters, M. | +11

5

Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV+ Men

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Gosens, K. | van der Burg, S. | Welters, M. | +10

6

Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment

enthalten in: Nature communications | 2023

von Haake, M. | Haack, B. | Schäfer, T. | +53

7

The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Santegoets, S. | Welters, M. | Schrikkema, D. | +9

8

Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions

enthalten in: Journal for immunotherapy of cancer | 2022

von Speetjens, F. | Welters, M. | Slingerland, M. | +16

9

T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation

enthalten in: Journal of clinical immunology | 2022

von Melsen, J. | van Ostaijen-Ten Dam, M. | van den Akker, E. | +9

10

T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation

enthalten in: Journal of clinical immunology | 2022

von Melsen, J. | van Ostaijen-ten Dam, M. | van den Akker, E. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]